.png)
Relevant Published Work
Includes previous work
Voices on Diversity: Overcoming Barriers to Pursue a Career in Science
2020
Lakeya McGill, Lathiena Manning Nerve, Sabrice Guerrier, Amaliris Guerra, Josiane Joseph, Jessica Silva-Fisher, Theodore Addo, Marquis Walker, Kamsi Odinammadu
Voices on Diversity: Multiple Paths to Becoming a Scientist
2020
Silva-Fisher J, Nervo LM, Addo T, Guerra A, Walker M, Guerrier S, McGill L, Brooks D, Joseph J, Johnson J, Ayombil F, Odinammadu K Mol Cell 2020 Dec 3;80(5):752-757
Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression.
2020
Silva-Fisher, J.M., Dang, H.X., White, N.M. et al. Nat Commun 11, 2156 (2020).
Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function.
2015
Cabanski CR, White NM, Dang HX, Silva-Fisher JM, Rauck CE, Cicka D, Maher CA: RNA Biol 2015, 12(6):628-
642.4615893. Pubmed Central PMID: 5864709
Transcriptome sequencingreveals altered long intergenic non-coding RNAs in lung cancer.
2014
White NM, Cabanski CR, Silva-Fisher JM, Dang HX, Govindan R, Maher CA: Genome Biol 2014, 15(8):429.4156652.
Pubmed Central PMID: 25116943
Long non-coding RNAs and Cancer
2011
Silva Jessica M and Smith David I. (2011) Long non-coding RNAs and Cancer in Kevin V. Morris (Eds), Long
Non-coding RNAs: Regulation of Gene Expression and Drivers of Natural Selection, (Chapter 9) The
Scripps Research Institute, La Jolla, California, Caister Academic Press
LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation.
2011
Silva JM, Boczek NJ, Berres MW, Ma X, Smith DI: RNA Biol 2011, 8(3):496-505. Pubmed Central PMID: 21532345
Identification of long stress-induced noncoding transcripts that have altered expression in cancer.
2010
Silva JM, Perez DS, Pritchett JR, Halling ML, Tang H, Smith DI: Genomics 2010, 95(6):355-362. Pubmed
Central PMID: 20214974
Akt-Induced Tamoxifen Resistance Is Associated With Altered FKHR Regulation
2007
Silva J, Cavazos DA, Donzis E, Friedrichs WE, Marciniak R, deGraffenried LA
Cancer Invest 2007;25(7):569-73
Inhibition of mTOR Activity Restores Tamoxifen Response in Breast Cancer Cells With Aberrant Akt Activity
2004
deGraffenried LA, Friedrichs WE, Russell DH, Donzis EJ, Middleton AK, Silva JM, Roth RA, Hidalgo M
Clin Cancer Res 2004 Dec 1;10(23):8059-67
NF-Kappa B Inhibition Markedly Enhances Sensitivity of Resistant Breast Cancer Tumor Cells to Tamoxifen
2004
deGraffenried LA, Chandrasekar B, Friedrichs WE, Donzis E, Silva J, Hidalgo M, Freeman JW, Weiss GR
Ann Oncol 2004 Jun;15(6):885-90
Eicosapentaenoic Acid Restores Tamoxifen Sensitivity in Breast Cancer Cells With High Akt Activity
2003
deGraffenried LA, Friedrichs WE, Fulcher L, Fernandes G, Silva JM, Peralba JM, Hidalgo M
Ann Oncol 2003 Jul;14(7):1051-6